Atopic Dermatitis in Elderly Patients: Discussing the Safety of Lebrikizumab in an 86-Year-Old Patient.
0 SAR
الدفع
المقدمة
هذا الفصل لـ
- Clinical Pharmacy
- Pharmacy
- Physician
- Resident / Fellow
الفئات ذات الصلة
- Key IL-13 Skin and Itch Data in Moderate-to-Severe AD.
- Atopic Dermatitis in Visible Areas Is a Real Challenge!
- Depth of Response & Stability of Response of Lebrikizumab
- Can You Reach EASI Targets Faster? – AD Case with Prof. Naiem Issa
- Deep Response to IL‑13 and IL‑4/13 Inhibition in AD
- Role of IL‑13 in Atopic Dermatitis (AD)
- Is FACE/Neck AD Treatable? A Real Patient Case with Dr. Fares Alkhayal
- Ebglyss Monthly Maintenance Dosing.Simply No lab monitoring , No boxed warning & No dose adjustment